Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 140
- Uncategorized
Washington May Require Fingerprint ID for Cannabis Purchases
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
New York Outlines Adult-Use Cannabis Regulation Package
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
Aurora Signs C$38.8m Deal To Pay Down Debt
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Medical
Medical Cannabis in France Faces Uncertain Future Amid Government Inaction
The future of France’s medical cannabis programme has been thrown into doubt this week as the government failed to introduce any sort of regulatory framework or allocate any funding in its annual budget.
- Press releases
Australian Success Story Alternaleaf Launches in the UK; On the Quest to Make Medical Cannabis More Accessible
Alternaleaf, the clinic that’s helped hundreds of thousands of Australians access medical cannabis, today is launching in the UK.
- Uncategorized
New York to Increase Medical Cannabis Access and Research
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
SAFER Act Passes Key Vote to Advance to Senate
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
British Columbia Allows Producers To Promote Products By Offering Samples
Cannabis producers with a federal licence in British Columbia will now be able to promote their products by offering samples to retailers for a ‘nominal fee’.
- Markets & Stocks
MGC Pharma In ‘Critical Financial Juncture’ As It Launches Restructuring Plan, Europes First Cannabis ETF To Be Merged As ‘No Longer Viable’, & More From Akanda
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in 2021, informed investors this week that due to adverse market conditions it ‘finds itself at a critical financial juncture’.
- Uncategorized
Proposed New Rules Could Be “Death” of Medical Cannabis in Maine
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
New York To Issue Over 1000 New Cannabis Licences In ‘Most Significant Expansion’ of Market
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Companies
OCT Emerges Strong from a Pivotal Year, Nears Release of Milestone Clinical Trial Results
This week, British pharmaceutical cannabis firm Oxford Cannabinoid Technologies (OCT) announced that the ‘final dose’ in its crucial Phase I clinical trial had been administered, with no ‘drug adverse effects observed’.
